Navigation Links
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
Date:9/30/2009

carcinogenicity following lifetime exposure to INT131. These results are enabling for INT131 to initiate planned Phase 3 clinical studies.

INT131 is a next-generation insulin sensitizer that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes. INT131 has been designed to provide a safer therapeutic tool for physicians and patients, which is complementary to available classes of medications, and allows for powerful glucose control and the opportunity for modification of the underlying disease. As a SPPARM, INT131 selectively modulates PPAR-gamma, and is ideally positioned to safely improve insulin resistance, addressing an important unmet medical need.

About InteKrin (www.InteKrin.com):

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of high value products by in-licensing clinical-stage therapeutic candidates that address significant unmet medical needs and rapidly move them through critical development stages. InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in nuclear receptors and metabolism, top scientists formerly with the Food and Drug Administration and key clinical and commercialization leaders.

SOURCE InteKrin Therapeutics Inc.


'/>"/>
SOURCE InteKrin Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... CHAPEL HILL, N.C. , July 31, 2015 /PRNewswire/ ... needs of customers who are increasingly mobile, increasingly connected, ... support a growing variety of customer interaction channels and ... of technology, including social media. According ... of the over the counter (OTC) segment in a ...
(Date:7/31/2015)... More than 1,500 substance abuse prevention and treatment specialists ... Indianapolis Aug. 2-6 for Community Anti-Drug Coalitions ... The week-long training, held at the JW Marriott, will ... biggest public health challenges – youth drug use. ... intensive training opportunity, offering more than 70 half-day and ...
(Date:7/31/2015)... RnRMarketResearch.com adds Syringes and ... that provides an overview of syringes and needles ... in-house databases, secondary and primary research. ... pipeline spread across 124 pages, talking about 13 ... 5 figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... Inc. (Nasdaq: VRUS ) has received fast track ... PSI-938 for the treatment of chronic hepatitis C virus (HCV) ... of HCV. In March 2011, Pharmasset presented ... antiviral activity and is generally safe and well tolerated, both ...
... The concept of smaller, thinner laparoscopic tools has ... since the advent of laparoscopic surgery. Some prominent manufacturers ... past, but they did not perform to the standard ... how the extremely thin instruments would bend under the ...
Cached Medicine Technology:PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3New Micro Laparoscopic Instruments for the Bariatric Surgery Allow for Less Scarring and Pain than Ever Before Possible 2
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... an important workshop at its new True North Conference Center. The medical community, ... that the Jacksonville community may be more aligned in the effort to better ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reliable source of authentic ... new and refreshing show on Broadway, look no further than Hamilton. This American musical ... Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, and New York Drama ...
(Date:7/31/2015)... York (PRWEB) , ... July ... ... attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now available ... 2015 was well received with a 94% approval rating from the nationwide ...
(Date:7/31/2015)... ... July 31, 2015 , ... Transfinder, a software company based in ... were up 16 percent year-over-year for the first six months ended June 30, 2015 ... expected Transfinder to beat last year’s record-revenue mark of $10.4 million. , “We know ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... has been recognized in the 2015 Aster Awards national competition for a marketing ... serving Ocean City and surrounding communities in Coastal Maryland and Southern Delaware. , ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2
... , August is National Immunization Awareness ... 3 Department of Health Secretary Everette James today stressed ... Month. , , "Recommended vaccinations begin soon ... your family are up-to-date on these immunizations is critical to ...
... odds for chronic illness, review finds , MONDAY, Aug. 3 ... greater risk of developing kidney disease later in life, according ... found that people who were less than 5.5 pounds at ... disease than those with normal birth weight. The findings appear ...
... over their usefulness , MONDAY, Aug. 3 (HealthDay News) -- ... masks to ward off the flu, and the results of ... , Researchers in Hong Kong found that wearing a surgical ... transmission rates for the seasonal flu down, at least among ...
... , TEMPLE, Texas, Aug. 3 Scott ... at a national conference in Washington, DC titled "How Do They Do ... the only Texas health care system and one of 10 health systems ... , , The event was jointly hosted by The ...
... , , BEDFORD, Mass., Aug. 3 ... manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to ... June 27, 2009. , , Highlights of the quarter include: ... Revenues of $403.1 million. , Third quarter 2009 net income ...
... , , , , ... Uroplasty, Inc. (NYSE Amex: UPI ), a medical device ... dysfunctions, today reported financial results for the first fiscal quarter ended June ... the strategy we communicated at the beginning of the fiscal year of ...
Cached Medicine News:Health News:Corrected: Secretary of Health Urges Pennsylvanians to Get Immunized 2Health News:Corrected: Secretary of Health Urges Pennsylvanians to Get Immunized 3Health News:Low Birth Weight Might Raise Adult Kidney Disease Risk 2Health News:Surgical Masks Help Ward Off Flu, Maybe 2Health News:Surgical Masks Help Ward Off Flu, Maybe 3Health News:Surgical Masks Help Ward Off Flu, Maybe 4Health News:Scott & White Leadership Invited to National Forum on High Quality, Low-Cost Health Care 2Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 2Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 3Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 4Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 5Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 6Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 7Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 8Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 9Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 10Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 11Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 12Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 13Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 14Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 15Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 16Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 17Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 18Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 19Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 20Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 21Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 22Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 23Health News:Uroplasty Reports First Fiscal Quarter Results 2Health News:Uroplasty Reports First Fiscal Quarter Results 3Health News:Uroplasty Reports First Fiscal Quarter Results 4Health News:Uroplasty Reports First Fiscal Quarter Results 5Health News:Uroplasty Reports First Fiscal Quarter Results 6Health News:Uroplasty Reports First Fiscal Quarter Results 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: